Tag:

Celsion

Latest Headlines

Latest Headlines

ThermoDox a step away from orphan approval in Europe

Celsion ($CLSN), a drug-development company based in Columbia, MD, has announced that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency has issued a positive opinion

Heat-activated liposomes attracts SBIR grant

Celsion, a drug-development company based in Columbia, MD, has been awarded a $200,000 Phase I SBIR grant from the NIH for its low heat-activated liposomes, which the company says enables delivery of

Celsion's ThermoDox liver cancer trials get fast-tracked

Drug developer Celsion and sufferers of primary liver cancer received some good news from the FDA this week as the Columbia, MD-based company's first drug, ThermoDox, was granted fast-track status.